On the other hand, we examined the expression of the mesenchymal markers desmin and vimentin and found that the levels of both proteins were suppressed in the BNE-RRC-treated cancer cells (Figure 5), indicating the loss of MET in these cancer cells under the treatment with BNE-RRC. This evidence concerns the gene DES and cancer.